NEW YORK (GenomeWeb News) – A Department of Health and Human Services committee is still working on its recommendations for the HHS secretary on how to oversee the infant industry of direct-to-consumer genetic testing — including whether some of these tests should be considered medical devices and regulated as such by the Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.